{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T20:38:07Z","timestamp":1786653487052,"version":"build-2736575974"},"reference-count":24,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"3","license":[{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,5]]},"abstract":"<jats:title>Abstract:<\/jats:title>\n                  <jats:sec>\n                    <jats:title>AIMS:<\/jats:title>\n                    <jats:p>Despite decades of proven safety of paracetamol, serious and rare reactions such as Stevens\u2013Johnson Syndrome (SJS) and Toxic Epidermal Necrolysis (TEN) often occur in the Indian population. The current study aimed to understand the safety profile of this relatively safer drug, paracetamol, with respect to rare and serious adverse events, SJS\/TEN, based on data collected from the Indian population through the Pharmacovigilance Programme of India.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>METHODS:<\/jats:title>\n                    <jats:p>The collected, collated and analyzed all Individual Case Safety Reports with the use of paracetamol from the Indian population for the period January 1, 2010, to December 31, 2021, were reported to VigiBase and analyzed using the WHO database, VigiLyze.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>RESULTS:<\/jats:title>\n                    <jats:p>Analysis of the reported data showed that 313 SJS\/TEN adverse events were associated with the use of paracetamol. Disproportionality analysis of paracetamol-induced SJS\/TEN reactions in the Indian population using the Proportional Reporting Ratio (PRR), reporting odds ratio, and the information component indicated higher risk of paracetamol in the Indian population.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>CONCLUSIONS:<\/jats:title>\n                    <jats:p>The findings provide crucial insights into the extent of rare and infrequent SJS\/TEN associated with the use of paracetamol in the Indian population. Owing to the seriousness of reaction and the widespread use of paracetamol for fever-like illness, the prescribing physicians, pharmacists, and other healthcare professionals should closely monitor patients administered paracetamol for this potential rare reaction, SJS\/TEN.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.4103\/ijp.ijp_495_23","type":"journal-article","created":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T19:01:49Z","timestamp":1777575709000},"page":"250-258","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["Pharmacovigilance of paracetamol-induced Stevens\u2013Johnson Syndrome and toxic epidermal necrolysis in the Indian population"],"prefix":"10.4103","volume":"58","author":[{"given":"R. S.","family":"Ray","sequence":"first","affiliation":[{"name":"National Coordination Centre for Pharmacovigilance Programme of India, Indian Pharmacopoeia Commission, Ministry of Health and Family Welfare, Government of India, Ghaziabad, Uttar Pradesh, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ayushi","family":"Yadav","sequence":"additional","affiliation":[{"name":"National Coordination Centre for Pharmacovigilance Programme of India, Indian Pharmacopoeia Commission, Ministry of Health and Family Welfare, Government of India, Ghaziabad, Uttar Pradesh, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shashi","family":"Bhushan","sequence":"additional","affiliation":[{"name":"National Coordination Centre for Pharmacovigilance Programme of India, Indian Pharmacopoeia Commission, Ministry of Health and Family Welfare, Government of India, Ghaziabad, Uttar Pradesh, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jai","family":"Prakash","sequence":"additional","affiliation":[{"name":"National Coordination Centre for Pharmacovigilance Programme of India, Indian Pharmacopoeia Commission, Ministry of Health and Family Welfare, Government of India, Ghaziabad, Uttar Pradesh, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rajeev Singh","family":"Raghuvanshi","sequence":"additional","affiliation":[{"name":"National Coordination Centre for Pharmacovigilance Programme of India, Indian Pharmacopoeia Commission, Ministry of Health and Family Welfare, Government of India, Ghaziabad, Uttar Pradesh, India"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2026,5,1]]},"reference":[{"key":"R1-20260501","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1016\/j.amjmed.2016.03.022","article-title":"Stevens-Johnson syndrome and toxic epidermal necrolysis: An analysis of triggers and implications for improving prevention","volume":"129","author":"Miliszewski","year":"2016","journal-title":"Am J Med"},{"key":"R2-20260501","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1272\/jnms.83.216","article-title":"A review of the pathogenesis of toxic epidermal necrolysis","volume":"83","author":"Kinoshita","year":"2016","journal-title":"J Nippon Med Sch"},{"key":"R3-20260501","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1111\/ijd.12355","article-title":"Paracetamol induced Stevens-Johnson syndrome \u2013Toxic epidermal necrolysis overlap syndrome","volume":"53","author":"Biswal","year":"2014","journal-title":"Int J Dermatol"},{"key":"R4-20260501","doi-asserted-by":"crossref","first-page":"895","DOI":"10.3390\/medicina57090895","article-title":"Stevens-Johnson syndrome and toxic epidermal necrolysis: A review of diagnosis and management","volume":"57","author":"Frantz","year":"2021","journal-title":"Medicina (Kaunas)"},{"key":"R5-20260501","doi-asserted-by":"crossref","first-page":"6431694","DOI":"10.1155\/2018\/6431694","article-title":"An updated review of the molecular mechanisms in drug hypersensitivity","volume":"2018","author":"Chen","year":"2018","journal-title":"J Immunol Res"},{"key":"R6-20260501","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1016\/j.jaad.2016.12.024","article-title":"Pediatric Stevens-Johnson syndrome and toxic epidermal necrolysis in the United States","volume":"76","author":"Hsu","year":"2017","journal-title":"J Am Acad Dermatol"},{"key":"R7-20260501","doi-asserted-by":"crossref","first-page":"1250","DOI":"10.1111\/bjd.13989","article-title":"Epidermal necrolysis:60 years of errors and advances","volume":"173","author":"Heng","year":"2015","journal-title":"Br J Dermatol"},{"key":"R8-20260501","first-page":"131","article-title":"Acetaminophen-induced hepatotoxicity: A comprehensive update","volume":"4","author":"Yoon","year":"2016","journal-title":"J Clin Transl Hepatol"},{"key":"R9-20260501","doi-asserted-by":"crossref","first-page":"S278","DOI":"10.4103\/0976-237X.166838","article-title":"Paracetamol induced Steven-Johnson syndrome: A rare case report","volume":"6","author":"Rajput","year":"2015","journal-title":"Contemp Clin Dent"},{"key":"R10-20260501","doi-asserted-by":"crossref","first-page":"389","DOI":"10.4103\/0378-6323.110749","article-title":"A systematic review of the drug-induced Stevens-Johnson syndrome and toxic epidermal necrolysis in Indian population","volume":"79","author":"Patel","year":"2013","journal-title":"Indian J Dermatol Venereol Leprol"},{"key":"R11-20260501","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1111\/pde.13383","article-title":"Incidence, outcomes, and resource use in children with Stevens-Johnson syndrome and toxic epidermal necrolysis","volume":"35","author":"Antoon","year":"2018","journal-title":"Pediatr Dermatol"},{"key":"R12-20260501","doi-asserted-by":"crossref","first-page":"965","DOI":"10.2165\/00002018-200225130-00006","article-title":"Erythema multiforme, Stevens-Johnson syndrome and toxic epidermal necrolysis in children: A review of 10 years'experience","volume":"25","author":"Forman","year":"2002","journal-title":"Drug Saf"},{"key":"R13-20260501","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1186\/1750-1172-5-39","article-title":"Toxic epidermal necrolysis and Stevens-Johnson syndrome","volume":"5","author":"Harr","year":"2010","journal-title":"Orphanet J Rare Dis"},{"key":"R14-20260501","doi-asserted-by":"crossref","first-page":"1521","DOI":"10.1097\/CCM.0b013e31821201ed","article-title":"Toxic epidermal necrolysis and Stevens-Johnson syndrome: A review","volume":"39","author":"Gerull","year":"2011","journal-title":"Crit Care Med"},{"key":"R15-20260501","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1038\/sj.jid.5701033","article-title":"Stevens-Johnson syndrome and toxic epidermal necrolysis: Assessment of medication risks with emphasis on recently marketed drugs. The EuroSCAR-study","volume":"128","author":"Mockenhaupt","year":"2008","journal-title":"J Invest Dermatol"},{"key":"R16-20260501","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1007\/s40122-015-0040-z","article-title":"Recent advances in pediatric use of oral paracetamol in fever and pain management","volume":"4","author":"de","year":"2015","journal-title":"Pain Ther"},{"key":"R17-20260501","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1097\/MOP.0000000000001146","article-title":"Stevens-Johnson syndrome in children","volume":"34","author":"Ramien","year":"2022","journal-title":"Curr Opin Pediatr"},{"key":"R18-20260501","first-page":"52","article-title":"Clinical features, outcomes and treatment in children with drug induced Stevens-Johnson syndrome and toxic epidermal necrolysis","volume":"90","author":"Liotti","year":"2019","journal-title":"Acta Biomed"},{"key":"R19-20260501","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1016\/j.jid.2016.03.023","article-title":"Morbidity and mortality of Stevens-Johnson syndrome and toxic epidermal necrolysis in United States Adults","volume":"136","author":"Hsu","year":"2016","journal-title":"J Invest Dermatol"},{"key":"R20-20260501","doi-asserted-by":"crossref","first-page":"1835","DOI":"10.1007\/s00431-022-04407-w","article-title":"Paracetamol (acetaminophen) use in infants and children was never shown to be safe for neurodevelopment: A systematic review with citation tracking","volume":"181","author":"Cendejas-Hernandez","year":"2022","journal-title":"Eur J Pediatr"},{"key":"R21-20260501","doi-asserted-by":"crossref","first-page":"33","DOI":"10.3233\/JRS-180025","article-title":"Reporting of adverse drug reactions in India: A review of the current scenario, obstacles and possible solutions","volume":"30","author":"Mulchandani","year":"2019","journal-title":"Int J Risk Saf Med"},{"key":"R23-20260501","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1007\/s40264-023-01302-7","article-title":"Factors associated with underreporting of adverse drug reactions by health care professionals: A systematic review update","volume":"46","author":"Garc\u00eda-Abeijon","year":"2023","journal-title":"Drug Saf"},{"key":"R24-20260501","doi-asserted-by":"crossref","first-page":"385","DOI":"10.2165\/00002018-200629050-00003","article-title":"Under-reporting of adverse drug reactions: A systematic review","volume":"29","author":"Hazell","year":"2006","journal-title":"Drug Saf"},{"key":"R25-20260501","first-page":"e41116","article-title":"Association of acetaminophen with Stevens-Johnson syndrome and toxic epidermal necrolysis: Pharmacologic considerations and treatment options","volume":"15","author":"Spillers","year":"2023","journal-title":"Cureus"}],"container-title":["Indian Journal of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.4103\/ijp.ijp_495_23","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T19:38:21Z","timestamp":1786649901000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/ijp.ijp_495_23"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5]]},"references-count":24,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.4103\/ijp.ijp_495_23","relation":{},"ISSN":["0253-7613","1998-3751"],"issn-type":[{"value":"0253-7613","type":"print"},{"value":"1998-3751","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5]]},"assertion":[{"value":"2023-07-28","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-01-21","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}